ProCE Banner Activity

Considering Novel Mechanism ART for Overcoming Resistance

Medical Minute

In this case-based discussion, learn the data and recommendations for using novel mechanism agents when devising new ART regimens to regain viral suppression in people living with HIV experiencing ART failure

Released: July 10, 2023



Amanda Binkley

Amanda Binkley, PharmD, BCIDP, AAHIVP

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
Penn Presbyterian Medical Center
Pennsylvania, Philadelphia

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner


Supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Target Audience

This program is intended for physicians, registered nurses, pharmacists, nurse practitioners and physician associates/physician assistants, and other healthcare providers who care for persons with or at risk of HIV infection.

Program Learning Goal

The goal of this activity is to deliver the interprofessional HIV management team sustained education that will improve their knowledge and competence in making care decisions that address the needs of their individual patients.


Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The faculty reported the following relevant financial relationships or relationships to products or devices they have with ineligible companies related to the content of this educational activity:

Primary Author

Amanda Binkley, PharmD, BCIDP, AAHIVP

Clinical Pharmacy Specialist, Infectious Diseases
Department of Pharmacy
Penn Presbyterian Medical Center
Pennsylvania, Philadelphia

Amanda Binkley, PharmD, BCIDP, AAHIVP: consultant/advisor/speaker: ViiV.

The planners and content peer reviewers from Partners for Advancing Clinical Education, Clinical Care Options, LLC, and Practicing Clinicians Exchange do not have any relevant financial relationships to disclose.


The program has been made available online.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.


Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.